deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT00956059

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

Sponsor: Xi'an Jiaotong University

Conditions Focal Segmental Glomerulosclerosis
Interventions prednisone prednisone, FK506, MMF
Updated 6 times since 2017 Last updated: Aug 10, 2009 Started: Sep 30, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Focal Segmental Glomerulosclerosis, this trial is ongoing. The trial is conducted by Xi'an Jiaotong University and has accumulated 6 data snapshots since 2009. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Sep 2020 · 44 months · monthly snapshotUnknown Status~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotUnknown~Feb 2025 – present · 15 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Feb 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Feb 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  5. Sep 2020 — Jan 2021 [monthly]

    Unknown Status NA

▶ Show 1 earlier version

  1. Jan 2017 — Sep 2020 [monthly]

    Unknown Status NA

    First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Xi'an Jiaotong University
Data source: Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations